Skip to main navigation Skip to search Skip to main content

Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma

Research output: Contribution to journalArticleAcademicpeer-review

48 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)897-900
Number of pages4
JournalJournal of the American Academy of Dermatology
Volume55
Issue number5
DOIs
Publication statusPublished - 2006

Research programs

  • EMC MM-03-24-01
  • EMC MM-03-61-05-A

Cite this